Welcome to our dedicated page for EDGEWELL PERSONAL CARE Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EDGEWELL PERSONAL CARE Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EDGEWELL PERSONAL CARE Co's regulatory disclosures and financial reporting.
Edgewell Personal Care Company reported third‑quarter 2026 net sales of $570.1 million, up 1.7%, with net earnings from continuing operations of $12.3 million, or diluted EPS of $0.26. Organic net sales rose 1.1% as North America grew 3.0% and international markets declined 1.4%.
Gross margin from continuing operations fell to 42.5%, pressured by inflation, tariffs and mix, while adjusted gross margin slipped 30 basis points. Adjusted diluted EPS from continuing operations was flat year over year at $0.72, as lower gross profit and higher SG&A offset modest sales growth.
For the first nine months of fiscal 2026, Edgewell recorded a net loss of $62.6 million, versus net earnings of $56.0 million a year earlier. During the period the company booked a $37.4 million goodwill impairment and $71.9 million of restructuring and related charges tied to operating model changes and consolidation of Mexico and Wet Shave facilities. The sale of the Feminine Care segment to Essity generated approximately $340.0 million of proceeds; as of June 30, 2026, cash was $397.1 million and long‑term debt was $1,245.0 million.
Edgewell Personal Care Company reported third-quarter fiscal 2026 net sales of $570.1 million, up 1.7% year over year, with organic net sales up 1.1%. North America organic sales rose 3.0% on stronger Sun, Skin Care and Grooming volumes, while international organic sales declined 1.4% due to Middle East disruptions and Wet Shave manufacturing consolidation impacts.
Gross profit was $242.5 million and gross margin was 42.5%, down 210 basis points; adjusted gross margin was 44.5%. GAAP diluted EPS from continuing operations was $0.26, down from $0.46, while adjusted EPS held at $0.72. Adjusted EBITDA was $78.9 million versus $81.2 million a year earlier. Edgewell ended the quarter with $397.1 million in cash, net debt of $882.1 million and an adjusted net debt leverage ratio of 3.7x. For fiscal 2026, the company now expects reported net sales to grow 1.3%–1.8%, GAAP EPS to be flat to $0.20, adjusted EPS of $1.80–$2.00 and adjusted EBITDA of $250–$260 million, while continuing to incur about $92 million of restructuring and related charges and paying a quarterly dividend of $0.15 per share.
Dimensional Fund Advisors reports beneficial ownership of 1,856,415 shares of Edgewell Personal Care common stock, representing 4.0% of the class as of June 30, 2026. Dimensional has sole power to vote 1,802,862 shares and sole power to dispose of 1,856,415 shares, with no shared voting or dispositive authority.
The shares are held across underlying investment funds, group trusts and separate accounts for which Dimensional or its subsidiaries act as adviser or manager. All securities are owned by those Funds, and Dimensional disclaims beneficial ownership except as may be deemed under Section 13(d) of the Securities Exchange Act of 1934. To Dimensional’s knowledge, no single Fund’s interest exceeds 5% of the class.
Edgewell Personal Care Company ownership disclosures show American Century-related entities hold notable common stock positions. American Century Investment Management, Inc., American Century Companies, Inc. and Stowers Institute for Medical Research are each reported with 5,057,505 shares representing 11.0% of the class. American Century Capital Portfolios, Inc. is reported with 2,668,825 shares representing 5.8%. The filing is a joint Schedule 13G/A amendment that lists voting and dispositive powers and includes signatures consenting to a joint filing.
Edgewell Personal Care Company announced a leadership change in its supply chain organization. The company determined that Paul R. Hibbert will no longer serve as Chief Supply Chain Officer, effective June 1, 2026, and he will be eligible for payments and benefits under Edgewell’s Executive Severance Plan.
Edgewell also disclosed that Anthony Freve will join the company as Chief Supply Chain Officer, with his appointment effective on the same date, June 1, 2026. The company publicly announced this leadership transition on May 26, 2026.
Rubric Capital Management and David Rosen reported joint beneficial ownership of 4,000,000 shares of Edgewell Personal Care Company Common Stock, representing 8.56% of the class. The ownership percentage is calculated using 46,716,605 shares outstanding as of January 31, 2026 per the issuer's Form 10-Q. The Schedule 13G lists shared voting and shared dispositive power over the reported shares and identifies Rubric Capital Master Fund LP as having the right to receive dividends or sale proceeds on more than 5% of the class.
Edgewell Personal Care — Brandes Investment Partners filed an amended Schedule 13G reporting beneficial ownership of 6,723,479 common shares (14.39%) as of 03/31/2026. The filing shows shared voting power of 4,719,974 and shared dispositive power of 6,723,479.
The amendment is signed on 05/08/2026 by Glenn Carlson, Executive Director, and discloses the institutional holder's position in the issuer's common stock pursuant to Schedule 13G/A requirements.
Edgewell Personal Care Company reported Q2 fiscal 2026 net sales of $519.5 million, up 0.6% year over year, but profitability weakened. Net income from continuing operations fell to $4.0 million, or $0.09 diluted EPS, and total net loss was $10.6 million including discontinued operations.
The company closed the sale of its Feminine Care segment to Essity for approximately $340 million on a cash‑free, debt‑free basis, recording a $37.4 million goodwill impairment and a $2.2 million loss on assets held for sale. Feminine Care is now reported as discontinued operations.
Restructuring to streamline manufacturing and Wet Shave operations weighed on results, with $32.1 million restructuring charges in the first half and an expected $90 million of related charges in fiscal 2026. Adjusted diluted EPS from continuing operations was $0.60 for Q2 and $0.44 for the first six months, both below the prior-year periods despite slightly higher sales.
Edgewell Personal Care reported second-quarter fiscal 2026 net sales of $519.5 million, up 0.6%, while organic net sales fell 2.4%. GAAP diluted EPS from continuing operations dropped to $0.09 from $0.43, and adjusted EPS declined to $0.60 from $0.69.
Adjusted EBITDA from continuing operations was $73.8 million versus $84.7 million a year earlier, as gross margin and segment profits contracted despite productivity savings. The company reaffirmed its full-year outlook for organic net sales, adjusted EPS of $1.70–$2.10 and adjusted EBITDA of $245–$265 million, but lowered GAAP EPS guidance to flat–$0.40 due to higher restructuring and legal costs. Edgewell ended the quarter with $299.7 million in cash, a $418.8 million undrawn revolver and declared a $0.15 quarterly dividend.
Edgewell Personal Care Co reports a 13G filing: Vanguard Capital Management beneficially owns 2,378,243 shares of Common Stock, representing 5.09% of the class.
The filing states Vanguard Capital Management has sole voting power for 340,848 shares and sole dispositive power for 2,378,243 shares. Ownership is reported on behalf of Vanguard funds and managed accounts; the filing is signed 04/29/2026.